Search the LJMU website

Search results filters

1. How to squash money stresses

   Got money on the mind? Here are some student spending tips...

2. Is university for me?

   Considering university brings about a myriad of thoughts and feelings. Third year Adult Nursing student ,Natalie Beltran gives her perspective on why taking the leap back into study was worth it.

3. Olivia Coles Graduate Case Study | Student Futures

   Olivia Coles is a video journalist at the Times and the Sunday Times in London. Olivia graduated from LJMU with a degree in History and English and then went on to do an MA in Broadcast Journalism at City University, London.

4. Knife crime and gangs: how a decade of bad policy left deprived young people without real choice

   England’s dramatic rise in gang-related knife crime has been called a “disease” by the UK home secretary, Sajid Javid, and amid the daily drama of Brexit the prime minister, Theresa May, has called a summit of 100 experts to Downing Street to discuss the issue.

5. Interview with visiting law professor, Sarah Buhler

   Rachel Stalker, Senior Lecturer in Law and founder of the pro bono Legal Advice Centre at LJMU, recently hosted University of Saskatchewan law professor Sarah Buhler.

6. My experience working with orangutans

   MRes English student, Lindsay Wilkinson shares her insights into the orangutan volunteer project in Indonesian Borneo.

7. Amy Vicars Graduate Case Study | Student Futures

   Amy Vicars graduated with a Masters in Health Psychology in 2022 and now works for Everton in the Community as a Health and Wellbeing Coordinator.

8. Studying nursing as a mature student

   Final-year mature Adult Nursing student Kerri Jones explains her career journey and why it’s never too late to study at university.

9. Stacey hits the road to raise awareness of lockdown mental health

   The LJMU student telling anxiety to jog on...

10. Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use

    Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use